Google AI
The Times Australia
The Times World News

.

Machine learning plus insights from genetic research shows the workings of cells – and may help develop new drugs for COVID-19 and other diseases

  • Written by Shang Gao, Doctoral student in Bioinformatics, University of Illinois at Chicago

The Research Brief[1] is a short take about interesting academic work.

The big idea

We combined a machine learning algorithm with knowledge gleaned from hundreds of biological experiments to develop a technique[2] that allows biomedical researchers to figure out the functions of the proteins that turn genes on and off in cells, called transcription factors. This knowledge could make it easier to develop drugs for a wide range of diseases.

Early on during the COVID-19 pandemic, scientists who worked out the genetic code of the RNA molecules of cells in the lungs and intestines[3] found that only a small group of cells in these organs were most vulnerable to being infected by the SARS-CoV-2 virus. That allowed researchers to focus on blocking the virus’s ability to enter these cells. Our technique could make it easier for researchers to find this kind of information.

The biological knowledge we work with comes from this kind of RNA sequencing, which gives researchers a snapshot of the hundreds of thousands of RNA molecules in a cell as they are being translated into proteins. A widely praised machine learning tool, the Seurat analysis platform[4], has helped researchers all across the world discover new cell populations in healthy and diseased organs. This machine learning tool processes data from single-cell RNA sequencing without any information ahead of time about how these genes function and relate to each other.

Our technique takes a different approach by adding knowledge about certain genes and cell types to find clues about the distinct roles of cells. There has been more than a decade of research identifying all the potential targets of transcription factors.

Armed with this knowledge, we used a mathematical approach called Bayesian inference[5]. In this technique, prior knowledge is converted into probabilities that can be calculated on a computer. In our case it’s the probability of a gene being regulated by a given transcription factor. We then used a machine learning algorithm to figure out the function of the transcription factors in each one of the thousands of cells we analyzed.

We published our technique[6], called Bayesian Inference Transcription Factor Activity Model, in the journal Genome Research and also made the software freely available[7] so that other researchers can test and use it.

Why it matters

Our approach works across a broad range of cell types and organs and could be used to develop treatments for diseases like COVID-19 or Alzheimer’s. Drugs for these difficult-to-treat diseases work best if they target cells that cause the disease and avoid collateral damage to other cells. Our technique makes it easier for researchers to home in on these targets.

A blob is covered with tiny spheres A human cell (greenish blob) is heavily infected with SARS-CoV-2 (orange dots), the virus that causes COVID-19, in this colorized microscope image. National Institute of Allergy and Infectious Diseases[8]

What other research is being done

Single-cell RNA-sequencing has revealed how each organ can have 10, 20 or even more subtypes of specialized cells, each with distinct functions. A very exciting new development is the emergence of spatial transcriptomics, in which RNA sequencing is performed in a spatial grid that allows researchers to study the RNA of cells at specific locations in an organ.

A recent paper[9] used a Bayesian statistics approach similar to ours to figure out distinct roles of cells while taking into account their proximity to one another. Another research group combined spatial data with single-cell RNA-sequencing data[10] and studied the distinct functions of neighboring cells.

What’s next

We plan to work with colleagues to use our new technique to study complex diseases such as Alzheimer’s disease and COVID-19, work that could lead to new drugs for these diseases. We also want to work with colleagues to better understand the complexity of interactions among cells.

[Understand new developments in science, health and technology, each week. Subscribe to The Conversation’s science newsletter[11].]

Read more https://theconversation.com/machine-learning-plus-insights-from-genetic-research-shows-the-workings-of-cells-and-may-help-develop-new-drugs-for-covid-19-and-other-diseases-164992

Times Magazine

Why Is Professional Porsche Servicing Important for Performance and Longevity?

Owning a Porsche is a symbol of precision engineering, luxury, and high performance. To maintain t...

6 ways your smartwatch is lying to you, according to science

You check your smartwatch after a run. Your fitness score has dropped. You’ve burnt hardly any...

Has the adoption of electric vehicles led to new forms of electricity theft

Why the concern exists Electric vehicles (EVs) like the Tesla Model 3 or Nissan Leaf shift “fue...

Adobe Ushers in a New Era of Creativity with New Creative Agent and Generative AI Innovations in Adobe Firefly

Adobe (Nasdaq: ADBE) — the global technology leader that unleashes creativity, productivity and ...

CRO Tech Stack: A Technical Guide to Conversion Rate Optimization Tools

The fascinating thing is that the value of this website lies in the fact that creating a high-cali...

How Decentralised Applications Are Reshaping Enterprise Software in Australia

Australian businesses are experiencing a quiet revolution in how they manage data, execute agreeme...

The Times Features

realestate.com.au attracts the buyer for 9 in 10 listed…

New PropTrack data reveals the impact realestate.com.au has on property sales, with the  platfor...

The Hidden Threat Inside Data Centers: Why Fuel Degrada…

Data centers are designed with one overriding objective: uninterrupted operation. To achieve this...

Holidays: How to Book a Flight — and Protect Your Money…

For decades, booking an overseas holiday was a straightforward transaction: choose your destinat...

Olivia Colman, Kate Box to join an exclusive Live Q…

Fresh out of cinemas, JIMPA - the new film by acclaimed director Sophie Hyde (Good Luck to you, ...

Homemade Food: Cheaper Than Takeaway, Healthier Than Yo…

As the cost of living continues to bite across Australia, households are taking a harder look at...

The Coalition wants NDIS reform to focus on 3 things. H…

The government is expected to announce further changes to the National Disability Insurance Sche...

Power Bills: What Are the Options to Decrease What a Fa…

Australian households are being told, repeatedly, to “use less power.” Turn off lights. Shorten...

The Times Launches Dedicated Property Advertising Platf…

In a significant expansion of its digital media offering, The Times has formally launched TimesA...

Can I get a free flu shot? And will it cover ‘super K’?…

For many of us, flu can mean a nasty few weeks of illness. But for the very young and old, and...